EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

The Impact of COVID-19 Pandemic on ESBL-Producing Enterobacterales Infections: A Scoping Review

Ha Thi Thao Mai iD, J Luis Espinoza iD

Antibiotics · 16.06.2023 · 12 (6) · 1064

DOI: 10.3390/antibiotics12061064 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Antibiotics, online erschienen am 16.06.2023. Verfasst von Ha Thi Thao Mai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho City 900000, Vietnam. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several studies have reported an increased frequency of colonization and/or infection with antibiotic-resistant bacteria (ARB) during the COVID-19 pandemic. Extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) are a group of bacteria with intrinsic resistance to multiple antibiotics, including penicillins, cephalosporins, and monobactams. These pathogens are easy to spread and can cause difficult-to-treat infections. Here, we summarize the available evidence on the impact of the COVID-19 pandemic on infections caused by ESBL-PE. Using specific criteria and keywords, we searched PubMed, MEDLINE, and EMBASE for articles published up to 30 March 2023 on potential changes in the epidemiology of ESBL-E since the beginning of the COVID-19 pandemic. We identified eight studies that documented the impact of COVID-19 on ESBL-E. Five studies were focused on assessing the frequency of ESBL-PE in patient-derived specimens, and three studies investigated the epidemiological aspects of ESBL-PE infections in the context of the COVID-19 pandemic. Some of the studies that were focused on patient specimens reported a decrease in ESBL-PE positivity during the pandemic, whereas the three studies that involved patient data (1829 patients in total) reported a higher incidence of ESBL-PE infections in patients hospitalized for COVID-19 compared with those with other conditions. There are limited data on the real impact of the COVID-19 pandemic on the epidemiology of ESBL-PE infections; however, patient-derived data suggest that the pandemic has exacerbated the spread of these pathogens.

Schlagwörter

Stichwörter der Autor:innen

Enterobacterales extended-spectrum β-lactamase-producing Enterobacteralesantibiotic-resistant bacteriamultidrug-resistant organisms

Autor:innen und Institutionen

  • Department of Biochemistry, Faculty of Medicine, Can Tho University of Medicine and Pharmacy, Can Tho City 900000, Vietnam.
  • Faculty of Health Sciences, Kanazawa University, Kanazawa 920-0942, Ishikawa, Japan.

ORCID-Profile: Ha Thi Thao Mai, J Luis Espinoza

Zitieren

APA

Mai, H. T. T., & Espinoza, J. L. (2023). The Impact of COVID-19 Pandemic on ESBL-Producing Enterobacterales Infections: A Scoping Review. Antibiotics, 12(6), 1064. https://doi.org/10.3390/antibiotics12061064

Vancouver

Mai HTT, Espinoza JL. The Impact of COVID-19 Pandemic on ESBL-Producing Enterobacterales Infections: A Scoping Review. Antibiotics. 2023;12(6):1064. doi:10.3390/antibiotics12061064

BibTeX
@article{Mai2023,
  author = {Mai, Ha Thi Thao and Espinoza, J Luis},
  title = {The Impact of COVID-19 Pandemic on ESBL-Producing Enterobacterales Infections: A Scoping Review},
  journal = {Antibiotics},
  year = {2023},
  volume = {12},
  number = {6},
  pages = {1064},
  doi = {10.3390/antibiotics12061064}
}
Kostenlos starten →